12.09.25 -- When Preclinical Models Distort The Patient

Gene therapy holds promise for treating genetic diseases. Explore the latest in gene therapy with expert insights on AAV vector integrity, dPCR-based solutions, assay design, and reference standards.

Cost efficiencies and expertise again go hand in hand, with companies often outsourcing or partnering primarily to gain access to manufacturing know-how.

A single-site "landing pad" CHO cell line simplifies the creation of mammalian display libraries, enabling consistent, single-copy integration of target sequences for biologic drug discovery.

A modular cell line development platform helps overcome biologic complexity. Learn how flexibility and expert support drive success from early development through commercial manufacturing.

Discover how the Sinclair Nanopig® is advancing preclinical research as a cost-effective, human-relevant alternative to traditional non-rodent models.

See how the team developed innovative analytical methods to support both pre-clinical studies and future GMP production, all while meeting demanding project goals and tight deadlines.

Gain insights into a “simul-spray” process pioneering for combining small and large molecules into a single, atomized drug product for inhalation administration.

Assimilate how an amorphous solid dispersion (ASD) of acalabrutinib was designed using in vitro studies and in silico modeling. Understand how ASD formulations can enhance bioavailability.